GoApptiv Private Limited
Gogulakrishnan V is a highly experienced and knowledgeable professional in the healthcare industry with 23 years of experience. Gogulakrishnan has worked in various managerial roles in companies such as GoApptiv Private Limited, BRITISH BIOLOGICALS PVT LTD, RAPTAKOS BRETT AND COMPANY LIMITED, Zydus Group, Signutra, Abbott, and GSK. Gogulakrishnan V is a skilled leader in product launch, market analysis, strategy execution, and hospital sales. Gogulakrishnan holds a Master of Business Administration from Pondicherry University and has a strong background in nutrition, pharma, general, FMCG, OTC Gyn, and IVF divisions. Gogulakrishnan V is committed to promoting ethical standards and best practices within the industry.
This person is not in any offices
GoApptiv Private Limited
1 followers
GoApptiv is revolutionising the healthcare and pharmaceutical space in India with its unique ‘phygital’ model that provides quality healthcare access to extra-urban and rural India. Our platform aims to drive agile market access, optimise patient experiences, deliver organisational growth and empower every stakeholder in the healthcare ecosystem. With our combination of proprietary technology and on-ground field force, we have been able to reach: 27 States, 200,000+ villages, 3,424 markets, 3,100 Tehsils, 618 districts. The Indian Healthcare Industry is at the cusp of a “digital revolution”. However, while physicians and patients are individually adapting to ‘digital’, healthcare companies have been slow to embrace innovation. Traditional pharma companies tend to implement digital solutions in silos, and even these limited efforts are focussed solely on urban markets. The reason for this is that, extra-urban and rural markets are extremely fragmented and highly unstructured, therefore setting these companies back with significant costs (major entry barrier). GoApptiv has taken a lead in developing “smart-shared platforms” that address this gap. Our end-to-end solutions provide the digital infrastructure required to enable pharma companies to expand their footprint with cost efficiency and speed to market by leveraging economies of scale.